Clinic Revenue was Neuronetics’s largest product and service line in fiscal 2025, bringing in $86.98M of $149.16M (58%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Clinic Revenue | — | — | $4.45M | $86.98M | |||||
| Treatment Sessions | $45.43M | $51.65M | $51.45M | $44.41M | |||||
| Neurostar Advanced Therapy System | $17.39M | $17.09M | $16.09M | $15.54M | |||||
| Other | $2.39M | $2.61M | $2.91M | $2.24M | |||||
| Total | $65.21M | $71.35M | $74.89M | $149.16M |
Neuronetics brought in $149.16M from its four product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 99.2% from $74.89M in fiscal 2024. Clinic Revenue was the largest at $86.98M (58.3%), ahead of Treatment Sessions at $44.41M (29.8%) and Neurostar Advanced Therapy System at $15.54M (10.4%). The remaining line, Other, brought in $2.24M.
Compared with fiscal 2024, Clinic Revenue grew fastest, up 1,856.7% to $86.98M, while Treatment Sessions fell the most, down 13.7% to $44.41M.
Neuronetics began breaking out Clinic Revenue in fiscal 2024, when it brought in $4.45M.
U.S was Neuronetics’s largest region in fiscal 2025, bringing in $146.05M of $149.16M (98%).
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| U.S | $63.41M | $69.34M | $72.49M | $146.05M | |||||
| United States | — | — | — | — | |||||
| International | $1.80M | $2.01M | $2.40M | $3.11M | |||||
| Total | $65.21M | $71.35M | $74.89M | $149.16M |
Neuronetics brought in $149.16M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 99.2% from $74.89M in fiscal 2024. U.S was the largest at $146.05M (97.9%), ahead of International at $3.11M (2.1%).
Compared with fiscal 2024, U.S grew 101.5% to $146.05M and International grew 29.4% to $3.11M. From fiscal 2022 to 2025, combined revenue from these regions grew from $65.21M to $149.16M, a compound annual growth rate of 31.8%. U.S's share of the total rose from 97.2% to 97.9%.
Clinical Services was Neuronetics’s largest segment in fiscal 2025, bringing in $86.98M of $149.16M (58%).
| Segment | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Medical Device | $65.21M | $71.35M | $70.45M | $62.18M |
| Clinical Services | — | — | $4.45M | $86.98M |
| Total | $65.21M | $71.35M | $74.89M | $149.16M |
Neuronetics brought in $149.16M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 99.2% from $74.89M in fiscal 2024. Clinical Services was the largest at $86.98M (58.3%), ahead of Medical Device at $62.18M (41.7%).
Compared with fiscal 2024, Clinical Services grew 1,856.7% to $86.98M, while Medical Device fell 11.7% to $62.18M.
Neuronetics began breaking out Clinical Services in fiscal 2024, when it brought in $4.45M.
Neuronetics (STIM) reports its revenue by product and service, by geography and by segment. In fiscal 2025, Clinic Revenue was its largest product and service line, bringing in $86.98M (58.3% of the total), followed by Treatment Sessions at $44.41M (29.8%).
Clinic Revenue was Neuronetics' largest product and service line in fiscal 2025, bringing in $86.98M, or 58.3% of the $149.16M total across its four product and service lines.
U.S was Neuronetics' largest region in fiscal 2025, bringing in $146.05M, or 97.9% of the $149.16M total across its two regions.
Clinical Services was Neuronetics' largest segment in fiscal 2025, bringing in $86.98M, or 58.3% of the $149.16M total across its two segments.
Among Neuronetics' product and service lines that make up at least 2% of revenue, Clinic Revenue grew fastest in fiscal 2025, up 1,856.7% from $4.45M to $86.98M.
Every figure comes from Neuronetics' annual financial filings, as reported. Each line keeps the name Neuronetics gives it, and years follow its fiscal calendar.
Neuronetics' revenue by product and service goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.